Search

everythinglearnresearchcommunity

for

Search:↓

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

Alopecia areata may be caused by the immune system attacking hair follicles.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Alopecia areata causes significant emotional distress, including high rates of depression and anxiety.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

Hair transplantation for Frontal Fibrosing Alopecia may work if the disease is inactive for 2 years and with ongoing treatment to maintain results.

Some people may temporarily lose more hair in certain areas after a hair transplant.

The Nd:YAG laser is a successful and safe way to treat ingrown and pincer nails.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

Apremilast did not work for treating severe alopecia areata.

Isotretinoin is effective for treating dissecting cellulitis, but recurrence is common.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

A rare form of alopecia causes hair thinning without bald spots and may be more common than thought, responding well to steroid treatment.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Both treatments for alopecia areata showed similar modest effectiveness.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.